Next Article in Journal
Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?
Previous Article in Journal
Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective
 
 
Article

Article Versions Notes

Curr. Oncol. 2023, 30(9), 8039-8053; https://doi.org/10.3390/curroncol30090583
Action Date Notes Link
article html file updated 12 September 2025 05:39 CEST Update https://www.mdpi.com/1718-7729/30/9/583/html
article html file updated 9 August 2025 20:13 CEST Update -
article html file updated 31 August 2023 06:18 CEST Original file -
article pdf uploaded. 31 August 2023 06:17 CEST Updated version of record https://www.mdpi.com/1718-7729/30/9/583/pdf
article xml uploaded. 31 August 2023 06:17 CEST Update https://www.mdpi.com/1718-7729/30/9/583/xml
article xml file uploaded 31 August 2023 06:17 CEST Original file -
article supplementary file uploaded. 30 August 2023 17:25 CEST - https://www.mdpi.com/1718-7729/30/9/583#supplementary
article pdf uploaded. 30 August 2023 17:25 CEST Version of Record https://www.mdpi.com/1718-7729/30/9/583/pdf-vor
Back to TopTop